Nancy is an accomplished senior executive and thought leader with over 20 years’ success in the healthcare and biotech industries. She is a passionate and compassionate leader of high performing teams with deep expertise in designing effective customer marketing strategies and building commercial capabilities that drive performance.
Fueled by seeing the impact new treatments can have on people who have chronic disease first hand, she pursued a career in healthcare. Nancy’s broad commercial leadership experience includes global commercial operations, marketing, sales, sales management, and market access, across specialty and primary care. Nancy has held roles of increasing responsibility at Schering-Plough, now Merck, Wyeth, now Pfizer, and Bristol-Myers Squibb where she held roles of increasing responsibility including Head, Worldwide Commercial Operations for all priority markets and therapy areas. Nancy was CEO, Adhera Therapeutics and served on several boards including the Board of Managers for HATCH@Takeda and Eved a private fintech software firm. She currently serves as an Independent Board Member for FemmePharma Consumer Health and is an Advisory Board Member for several organizations including Evolution Road, and the Digital Health Coalition.
Nancy is currently VP, Business Transformation at Novartis and previously was VP and Head, Patient Specialty Services, Neuroscience at Novartis where she led a team dedicated to revolutionizing access to medications for all patients.
A former Working Mother Magazine cover mom, Nancy is married to her husband Robert and mom to two wonderful children and two somewhat well-behaved dogs. In her free time Nancy enjoys running, cooking and reading.
Kate Miller Named Chief Strategy Officer at Evolution Road
Kate Miller has been promoted to the position of Chief Strategy Officer from the position of Digital Innovation/Commercialization Practice Lead. She has been with the firm for nearly 14 years and was previously the Vice President of Strategy. Kate will be responsible for ER’s market vision, positioning and branding, thought leadership and intellectual property.
August 30, 2021
Announcing Decoding Digital Health for Life Sciences
The ER team is pleased to invite you to a new industry event called Decoding Digital Health for Life Sciences, running June 15-16, 2021. This event will help Life Science brand and commercial teams better understand the digital health opportunity and how to leverage digital health to improve patient outcomes and drive commercial success. Decoding Digital Health was co-created by Evolution Road and ER's own Paul Ivans & Todd Kolm are the conference co-chairs.
April 20, 2021
Using big data to boost engagement, conversion and revenue
One of the country’s largest pharmaceutical companies and a top health information technology company had always wanted to work together, yet the right opportunity never presented itself. Taking an independent, objective view, we found one driven by data.
With the objective of driving awareness and education across an entire portfolio and, ultimately, incremental treatment rates and improved patient outcomes, we layered multiple data sources to inform a multi-pronged digital communications strategy that reached three million patients and drove $40 million in incremental revenue.
March 23, 2021
Reimagining patient engagement
A multinational pharmaceutical manufacturer knew there was room to improve engagement and adherence amongst its diabetes patients.
Where standard approaches fell short, we created the digital strategy, guided program development and piloted a multi-touch engagement program designed to meet patients on their terms—with deep personalization and less friction.
March 23, 2021
Eliminating care gaps through digital innovation
One of the world’s top pharmaceutical companies sought to narrow gaps in care across its entire vaccine portfolio.
Cultivating a collaborative partnership for our client with CareSpeak, an OptimizeRx company that offers an interactive health messaging platform, we crafted a comprehensive member communications strategy that sparked measurable, meaningful engagement.
March 22, 2021
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021
Realizing the Promise of Digital Health Partnerships
Why have commercial life sciences, with a track record of going it alone, pivoted to partnerships with the Digital Health Ecosystem? How might a life science marketer get their organization primed for more/better partnering? How is the success of a partnership measured? What are some of the key watchouts in partnering?
December 18, 2020